AJP - Endo Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 281: E233-E241, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toth, M. J.
Right arrow Articles by Matthews, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toth, M. J.
Right arrow Articles by Matthews, D. E.
Vol. 281, Issue 2, E233-E241, August 2001

Recovery of 13CO2 from infused [1-13C]leucine and [1,2-13C2]leucine in healthy humans

Michael J. Toth, Michael J. MacCoss, Eric T. Poehlman, and Dwight E. Matthews

Departments of Medicine and Chemistry, University of Vermont, Burlington, Vermont 05405

Carbon (C) in the 1-position of leucine is released as CO2 with the decarboxylation of alpha -ketoisocaproate (KIC). Carbon in the 2-position of leucine undergoes several additional metabolic steps before entering the tricarboxylic acid (TCA) cycle in the 1-position of acetyl-CoA, where it can be released as CO2 or be incorporated into other compounds. This study examined the metabolic fate of C in the 2-position of leucine. We infused 11 healthy subjects with [1-13C]leucine and [1,2-13C2]leucine for 3.5-4 h to measure leucine kinetics and the oxidation of the tracers from enrichments of 13C in blood and expired CO2. The fraction of leucine infused that was oxidized (fox) was used to define the degree of recovery of the 13C label(s) for each tracer. As expected, leucine appearance (means ± SE) did not differ between tracers (13C1: 92.1 ± 3.1 vs. 13C2: 89.2 ± 3.2 µmol · kg-1 · h-1) when calculated using plasma leucine enrichments as an index of intracellular enrichment. A small (3%) but significant (P = 0.048) difference between tracers was found when KIC was used to calculate leucine appearance (13C1: 118.0 ± 4.1 vs. 13C2: 114.4 ± 4.5 µmol · kg-1 · h-1). The value of fox was 14 ± 1% for [1,2-13C2]leucine and was lower than the fox for [1-13C]leucine (19 ± 1%). From the fox data, we calculated that the recovery of the 2-13C label in breath CO2 was 58 ± 6% relative to the 1-13C label. These findings show that, although a majority of the 2-13C label of leucine is recovered in breath CO2, a significant percentage (~42%) is retained in the body, presumably by transfer to other compounds, via TCA exchange reactions.

leucine oxidation; leucine kinetics


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Toth, C. K. Sites, and D. E. Matthews
Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy
Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E639 - E646.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Toth, D. E. Matthews, R. P. Tracy, and M. J. Previs
Age-related differences in skeletal muscle protein synthesis: relation to markers of immune activation
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E883 - E891.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H. Hasegawa, T. Matsukawa, Y. Shinohara, and T. Hashimoto
Kinetics of Sequential Metabolism from D-Leucine to L-Leucine via alpha -Ketoisocaproic Acid in Rat
Drug Metab. Dispos., December 1, 2002; 30(12): 1436 - 1440.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
G van Hall, M Sacchetti, and G Radegran
Whole body and leg acetate kinetics at rest, during exercise and recovery in humans
J. Physiol., July 1, 2002; 542(1): 263 - 272.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online